Holen Sie sich die Stockscreener-App
83.57
0.33%
-0.50
Handel nachbörslich:
83.44
-0.13
-0.16%
Schlusskurs vom Vortag:
$84.07
Offen:
$84.87
24-Stunden-Volumen:
467.77K
Relative Volume:
0.53
Marktkapitalisierung:
$2.90B
Einnahmen:
$635.89M
Nettoeinkommen (Verlust:
$171.92M
KGV:
19.18
EPS:
4.357
Netto-Cashflow:
$151.36M
1W Leistung:
-3.69%
1M Leistung:
-5.25%
6M Leistung:
-11.15%
1J Leistung:
-25.32%
1-Tages-Spanne:
$81.55
$84.87
1-Wochen-Bereich:
$81.55
$86.38
52-Wochen-Spanne:
$60.10
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Firmenname
Transmedics Group Inc
Sektor
Branche
Telefon
(978) 552-0900
Adresse
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
83.57 | 2.96B | 635.89M | 171.92M | 151.36M | 4.357 |
ABT
Abbott Laboratories
|
98.81 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.26 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.60 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.66 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.32 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Hochstufung | Needham | Hold → Buy |
| 2025-10-13 | Eingeleitet | Jefferies | Buy |
| 2025-09-16 | Eingeleitet | Evercore ISI | Outperform |
| 2025-09-04 | Eingeleitet | Stifel | Hold |
| 2024-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Herabstufung | Needham | Buy → Hold |
| 2024-10-29 | Bestätigt | Needham | Buy |
| 2024-10-29 | Bestätigt | Oppenheimer | Outperform |
| 2024-09-24 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-08-21 | Eingeleitet | Needham | Buy |
| 2024-06-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Eingeleitet | Stephens | Overweight |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2019-05-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-05-28 | Eingeleitet | Cowen | Outperform |
| 2019-05-28 | Eingeleitet | JP Morgan | Overweight |
| 2019-05-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten
TransMedics offers a unique organ transplant te... - Pluang
TransMedics Offers Attractive Entry Point, With Upside Potential Outweighing Risks (TMDX) - Seeking Alpha
Investors urged to act on possible TransMedics leadership breaches and seek legal relief. - Pluang
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - kentuckytoday.com
Investors Purchase Large Volume of TransMedics Group Put Options (NASDAQ:TMDX) - MarketBeat
A Look at TransMedics Group Inc (TMDX) After 3.6% Decline -- GF Value $158.92 vs Price $83.90 - GuruFocus
(TMDX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
TransMedics Group, Inc. (TMDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and TransMedics Group (TMDX) - The Globe and Mail
Donald TrumpTRANSMEDICS GROUP INC Trump Trade on Jul. 08, 2026 - Quiver Quantitative
TransMedics Group, Inc. (TMDX) Stock Analysis: A 12.59% Potential Upside in the Revolutionary Organ Transplant Space - DirectorsTalk Interviews
TMDX Q2 2026 Earnings: EPS Misses Estimate as Shares Edge LowerDiluted EPS Report - careplusvn.com
An Organ Transplant Company With Its Own Fleet Of Aircraft – Insider Weekends (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group stock holds near model value as analysts stay positive - AD HOC NEWS
TransMedics Group, Inc.Common Stock (NQ: TMDX - The Chronicle-Journal
TransMedics Stock: Waiting On 2027 Catalysts (NASDAQ:TMDX) - Seeking Alpha
2 Stocks Down 28% and 34% to Buy and Hold - The Motley Fool
TMDX: Major growth ahead with new transplant tech, European expansion, and strong financial targets - TradingView
TransMedics Group Jumps 6.5% Amid Sector-Wide Rally - AlphaStreet
Insider Buying: TransMedics Group (NASDAQ:TMDX) Director Buys 1,336 Shares of Stock - MarketBeat
Director buys TransMedics (TMDX) stock at $81.63 a share - Stock Titan
Weekly Recap: TMDX CFO appointment and TD Cowen $120 target - TradingView
TMDX: Plans for rapid transplant volume growth, global expansion, and new organ launches drive outlook - TradingView
(TMDX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Is TransMedics Group Inc (TMDX) a Bargain After 3.4% Drop? GF Value Says Undervalued - GuruFocus
TransMedics Slides After CFO Transition News Despite Reaffirmed 2026 Outlook - quiverquant.com
TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.1%What's Next? - MarketBeat
Needham reiterates Buy on TransMedics stock, names new CFO By Investing.com - Investing.com UK
TransMedics (NASDAQ: TMDX) Appoints Fernando Araujo as CFO with $590K Base Salary - Kalkine Media
TransMedics appoints Fernando Araujo as CFO to drive growth, reiterates 2026 revenue guidance of $737-$757M. - Pluang
TransMedics Appoints Fernando Araujo as CFO with Detailed Compensation and Transition Plan - Kalkine Media
TransMedics names Fernando Araujo as CFO, reaffirms 2026 outlook By Investing.com - Investing.com India
(TMDX) TransMedics Expects Full Year 2026 Revenue Range $737M$757M, vs. FactSet Est of $743.1M - marketscreener.com
TransMedics Group, Inc. Reiterates Revenue Guidance for the Full Year 2026 - marketscreener.com
TransMedics Group (NASDAQ:TMDX): Is the Market Too Cautious? - Kalkine Media
TransMedics names Fernando Araujo as CFO, reaffirms 2026 outlook - Investing.com
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
NFLX: Netflix Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
TMDX Stock Rallies As Analyst Sees 77% Upside — Here’s Why - Stocktwits
TransMedics Group (TMDX) Institutional Ownership 2026 - MarketBeat
TMDX Reiterated by TD Cowen -- Price Target Maintained at $120 - GuruFocus
TransMedics Group's (TMDX) "Buy" Rating Reiterated at TD Cowen - MarketBeat
TransMedics: Slowing Growth Brings Its Valuation Into Question (NASDAQ:TMDX) - Seeking Alpha
Law firm probes TransMedics officers for possib... - pluang.com
TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Buy Ratings and 8.14% Upside Potential - DirectorsTalk Interviews
Jupiter Topco LLC Makes New Investment in TransMedics Group, Inc. $TMDX - MarketBeat
The Manufacturers Life Insurance Company Acquires Shares of 17,159 TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group, Inc. $TMDX Position Increased by FirstWave Capital Management LLC - MarketBeat
19,289 Shares in TransMedics Group, Inc. $TMDX Bought by Corient Private Wealth LP - MarketBeat
Legal & General Group Plc Invests $5.29 Million in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group, Inc. $TMDX Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Finanzdaten der Transmedics Group Inc-Aktie (TMDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Transmedics Group Inc-Aktie (TMDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Option Exercise |
2.21 |
19,285 |
42,620 |
26,266 |
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Sale |
75.06 |
9,624 |
722,377 |
16,642 |
2.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):